May 13 (Reuters) - Leap Therapeutics Inc LPTX.O:
LEAP THERAPEUTICS Q1 NET INCOME USD -15.435 MILLION
LEAP THERAPEUTICS Q1 OPERATING INCOME USD -15.917 MILLION
LEAP THERAPEUTICS Q1 OPERATING EXPENSES USD 15.917 MILLION
LEAP THERAPEUTICS Q1 EPS USD -0.37
LEAP THERAPEUTICS INC: HAS REDUCED ITS WORKFORCE BY APPROXIMATELY 50%
LEAP THERAPEUTICS INC: STRATEGIC RESTRUCTURING TO PRIORITIZE CLINICAL FOCUS ON DEVELOPMENT OF SIREXATAMAB IN CRC
Source text: ID:nPn4qjmLwa
Further company coverage: LPTX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.